Robb Gary Charles's Form 4 filing
Corcept Therapeutics Inc (CORT) · filed Nov 21, 2022
- Accession no.
- 0000899243-22-036534
- Filed
- Nov 21, 2022
- Trade date
- Nov 17-18, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $614.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Robb Gary CharlesCIK 0001529655 | Officer (Chief Business Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2022 | Common Stock | SSaleDisposed | −10,000 | $26.06 | −$260,600 | 39,544 | Direct | |
| Nov 18, 2022 | Common Stock | SSaleDisposed | −13,401 | $26.43 | −$354,188.43 | 26,143 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
The power of attorney under which this form was signed is on file with the Commission.